Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phibro Animal Health (PAHC) Accumulated Depreciation & Amortization (2016 - 2025)

Phibro Animal Health (PAHC) has 12 years of Accumulated Depreciation & Amortization data on record, last reported at $245.4 million in Q2 2024.

  • For Q2 2024, Accumulated Depreciation & Amortization fell 6.93% year-over-year to $245.4 million; the TTM value through Jun 2024 reached $245.4 million, down 6.93%, while the annual FY2024 figure was $245.4 million, 6.93% down from the prior year.
  • Accumulated Depreciation & Amortization reached $245.4 million in Q2 2024 per PAHC's latest filing, down from $263.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $263.6 million in Q2 2023 and bottomed at $198.9 million in Q2 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $234.4 million, with a median of $241.0 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 621.72% in 2020, then dropped 6.93% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $198.9 million in 2020, then grew by 12.12% to $223.1 million in 2021, then grew by 8.03% to $241.0 million in 2022, then grew by 9.4% to $263.6 million in 2023, then dropped by 6.93% to $245.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $245.4 million in Q2 2024, $263.6 million in Q2 2023, and $241.0 million in Q2 2022.